↓ Skip to main content

The risk-value trade-off: price and brand information impact consumers’ intentions to purchase OTC drugs

Overview of attention for article published in Journal of Pharmaceutical Policy and Practice, January 2021
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
4 tweeters

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
28 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The risk-value trade-off: price and brand information impact consumers’ intentions to purchase OTC drugs
Published in
Journal of Pharmaceutical Policy and Practice, January 2021
DOI 10.1186/s40545-020-00293-5
Authors

Lisa Aufegger, Celine Yanar, Ara Darzi, Colin Bicknell

Twitter Demographics

The data shown below were collected from the profiles of 4 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 28 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 28 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 6 21%
Student > Master 4 14%
Lecturer 3 11%
Researcher 2 7%
Student > Ph. D. Student 2 7%
Other 3 11%
Unknown 8 29%
Readers by discipline Count As %
Business, Management and Accounting 10 36%
Economics, Econometrics and Finance 2 7%
Pharmacology, Toxicology and Pharmaceutical Science 2 7%
Unspecified 1 4%
Linguistics 1 4%
Other 3 11%
Unknown 9 32%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 February 2021.
All research outputs
#10,529,374
of 18,461,354 outputs
Outputs from Journal of Pharmaceutical Policy and Practice
#185
of 307 outputs
Outputs of similar age
#169,906
of 356,171 outputs
Outputs of similar age from Journal of Pharmaceutical Policy and Practice
#1
of 1 outputs
Altmetric has tracked 18,461,354 research outputs across all sources so far. This one is in the 41st percentile – i.e., 41% of other outputs scored the same or lower than it.
So far Altmetric has tracked 307 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.8. This one is in the 37th percentile – i.e., 37% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 356,171 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them